Techdamentals
EMR · Emerson Electric Co.Industrials

What is Emerson Electric (EMR) stock worth?

Its intrinsic value, worked out four ways from Emerson Electric’s own reported numbers, against today’s price.
Fair value range
$115 – $141

Today’s price, $158, sits above the range. 23.3% above the $127.78 the four methods put it at.

OVERVALUED
After hours $157.60 ▲ 0.00% (not used in the valuation)
This range was worked out on November 11, 2026 from the company's reported numbers. The price is live, and the verdict compares today's price with that range.
A fair value isn’t a one-time number. The valuation methods run on EMR’s reported numbers, which change with every quarterly earnings report, and this range is worked out again at least once a month. The price moves every day. So a stock that reads as cheap today can read as fair, or expensive, a few weeks from now. A free account keeps the latest range in front of you, and a phone alert tells you when the price moves into a part of the range you pick.

Inside EMR’s full analysis

The real sections, opened with your free account.

Why this verdict Free account

The 4 methods put Emerson Electric’s fair value around $128 a share.

The 4 methods, side by side Free account
Method 1
Method 2
Method 3
Method 4
The business, in plain English Free account
  • Is it growing?
  • Does it make money?
  • Does it bring in cash?
  • Can it pay its bills?
  • What you pay for it

EMR’s latest earningsEmerson Electric Co.

Latest report: July to September 2026 (quarter ended Sep 30, 2026), reported Nov 4, 2026 before the open.

Earnings per share
$1.86In line
$1.85 expected
Stock after report
+2.4%
S&P 500 +1.6%
Next report
Feb 2, 2027
expected date
July to September 2026, in numbers
Earnings per share
$1.86, in line with the $1.85 analysts expected.
Revenue
$5.2 billion, up 7% from a year ago.
Profit
$750 million. It keeps 14¢ of every sales dollar as profit, up from 13¢ a year ago.

From the company's quarterly statements through Sep 30, 2026.

What the company expects next, in its own words
The following tables summarize the fiscal year 2027 guidance framework, which assumes returning ~$3.8B through ~$2.5B of share repurchases and ~$1.3B of dividends.

From the earnings release filed Nov 4, 2026.

The full read in the IV Calculator adds what the filing said that the headlines skipped, margins and cash for the quarter, how each part of the business did, and how EMR moved after its last eight reports.

See EMR’s full earnings read, free →
Not EMR? Value the stock you care about:
Educational tool, not investment advice. These are automated estimates from third-party data, impersonal and not tailored to anyone's situation. Data can be inaccurate and model assumptions can be wrong. We are not a registered investment adviser or broker-dealer. Always do your own research. See our methodology and terms.